Gyre Therapeutics, Inc. - Common Stock GYRE 深 沪
已收盘 08-01 16:00:00 美东时间
6.65
-0.400
-5.67%
华盛通- 最 高7.04
- 今 开6.98
- 成交量 10.35万股
- 最 低 6.57
- 昨 收 7.05
- 总市值 6.38亿
- 52周最高 19.00
- 市盈率 静 138.25
- 换手率 0.11%
- 52周最低 6.11
- 委 比 56.71%
- 总股本 9597.98万
- 历史最高 29271.2116
- 量 比 1.39
- 振 幅 6.67%
- 历史最低 -19.80
- 每 手 1
- 风险率 2.28%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Gyre Therapeutics Announces First Dosing in Phase 1 Trial of F230 for Pulmonary Arterial Hypertension in China
Gyre Therapeutics has initiated a Phase 1 clinical trial for its novel ETA receptor antagonist, F230, targeting pulmonary arterial hypertension (PAH). This marks Gyre's entry into the PAH field, a rare and severe cardiovascular condition with limited treatment options. F230, licensed from Eisai Co., Ltd., is designed to selectively block the ETA receptor to reduce pulmonary vascular remodeling and lower pulmonary pressure. The trial aims to asses...
06-10 11:00
Gyre Therapeutics Announces Closing of its Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Gyre Therapeutics closed an underwritten public offering of 2,555,555 shares of common stock, including an additional 333,333 shares, at $9.00 per share, raising approximately $23.0 million in gross proceeds. The company plans to use the net proceeds to advance its Phase 2 clinical trial for F351 in metabolic dysfunction-associated steatohepatitis (MASH)-related liver fibrosis, as well as for research and development, manufacturing, and general c...
05-29 20:01
MAC Copper, ATS, Pony AI And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were higher, with the Dow Jones index gaining around 500 points on ...
05-27 22:56
Gyre Therapeutics slumps 16%, prices $20M stock offering
Gyre Therapeutics (NASDAQ:GYRE) priced its previously announced underwritten public offering of ~2.22M shares at a public offering price of $9.00 per share. Underwriters have a 30 option to purchase...
05-23 15:35
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Tiziana Life Sciences (NASDAQ:TLSA) shares increased by 10.2% to $1.51...
05-23 05:05
Gyre Therapeutics shares are trading lower after the company announced a proposal for a public offering.
Gyre Therapeutics shares are trading lower after the company announced a propos...
05-23 04:38
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Kindly MD (NASDAQ:KDLY) stock increased by 454.4% to $21.62 during Mon...
05-12 20:09
Gyre Therapeutics Q1 Sales $22.06M Miss $28.70M Estimate
Gyre Therapeutics (NASDAQ:GYRE) reported quarterly sales of $22.06 million which missed the analyst consensus estimate of $28.70 million by 23.14 percent. This is a 18.82 percent decrease over sales of $27.17 million
05-09 18:12
Gyre Therapeutics shares are trading lower. The company reported Q4 financial results.
Gyre Therapeutics shares are trading lower. The company reported Q4 financial r...
03-19 01:17
Gyre Therapeutics Sees FY25 Revenue $118M-$128M
Full Year 2025 Financial GuidanceFor the full year 2025, the Company expects to generate revenues of $118 to $128 million, representing growth of 11.3% to 20.8% over 2024 revenue, primarily driven by the anticipated
03-18 04:19
